24 Nov 2020 --- In its “biggest move” since founding, Aker BioMarine is creating Lysoveta, a new business segment devoted to commercializing a supplement of the same name. The new offering for the eye and brain markets consists of lysophosphatidylcholine (LPC)-bound EPA and DHA from krill oil.
